EIKN

Conviction 43HealthcareScan · Thu, Sep 24, 2026

Eikon Therapeutics, Inc. (EIKN) closed at $8.24 (+1.35%) on Sep 24, 2026. Price is below its 50-day. RSI(14) 37, -49.3% from its 52-week high, -45.1% year to date. Sector: Healthcare · Biotechnology.

EIKN$8.24+1.35%

ResistanceSupportVol 14

Vol MA14 844.01K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Eikon Therapeutics, Inc.Biotechnologywww.eikontx.com ↗

Price8.24

Change+1.35%

Gap-0.62%

Rel volume2.60×

Avg volume693.97K

Avg $ vol6.48M

SMA 209.79

SMA 5010.02

SMA 200—

Price vs 50-17.73%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 10.54

RSI (14)37

MACD hist-0.19

MACD cross—

Stoch %K / %D14 / 12

ADX (14)16

+DI / −DI19 / 27

RSI divergence—

MACD divergence—

ATR %10.32%

ADR %7.94%

52w high16.26

52w low8.13

From 52w high-49.32%

Above 52w low+1.35%

New 52w highNo

SqueezeOff

Bollinger width45.38%

%B0.15

Donchian pos11.32%

Donchian high12.24

Donchian low7.73

AVWAP (52w high)11.28

vs AVWAP high-26.97%

AVWAP (52w low)8.12

vs AVWAP low+1.44%

OBV trendUp

Chaikin MF (20)-0.19

Today vs 20d2.60×

Avg vol (14d)844.01K

Avg vol (20d)693.97K

Avg $ vol (20d)6.48M

Market cap446.32M

RS Rating—

RS 3m (vs SPY)-20.84%

RS 6m (vs SPY)-42.38%

RS line new highNo

Trend template—

Technical rank11.7

1 week-4.19%

1 month-34.34%

3 months-16.35%

6 months-25.56%

1 year—

YTD-45.07%

P/E—

P/B0.96

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current9.89

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional48.88%

Ent. value303.71M

Revenue—

Net income-88.41M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out54.14M

Employees384

ListedThu, Feb 5, 2026

Free float26.6M

Float %49.1%

Short interest5.28M

Days to cover10.3d

Short volume68.9%

Squeeze score99 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.63 vs −$1.61

Last surprise-1.2% miss

Setup gradeD

Conviction43 / 100

Pattern quality—

Tech rank11.7 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance13.75

Support8.59

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EIKN

All disclosures →

No recent disclosed trades by Congress in EIKN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EIKN

No recent insider (Form 4) filings in EIKN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in EIKN · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.